487 related articles for article (PubMed ID: 15569335)
21. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
22. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
23. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Hong SY; Yang DH; Chang SK
Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
[TBL] [Abstract][Full Text] [Related]
24. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
25. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation.
Koyama K; Usami T; Takeuchi O; Morozumi K; Kimura G
Nephrol Dial Transplant; 2002 May; 17(5):916-22. PubMed ID: 11981084
[TBL] [Abstract][Full Text] [Related]
27. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
28. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation.
Hirsch S; Pia De la Maza M; Yañez P; Glasinovic A; Petermann M; Barrera G; Gattas V; Escobar E; Bunout D
Clin Cardiol; 2002 Nov; 25(11):495-501. PubMed ID: 12430779
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
30. The effect of vitamin B12 on total plasma homocysteine concentration in folate-replete hemodialysis patients.
Arnadottir M; Hultberg B
Clin Nephrol; 2003 Mar; 59(3):186-9. PubMed ID: 12653261
[TBL] [Abstract][Full Text] [Related]
31. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
32. Intravenous treatment of hyperhomocysteinemia in patients on chronic hemodialysis--a pilot study.
Pöge U; Look M; Gerhardt T; Klehr HU; Sauerbruch T; Woitas RP
Ren Fail; 2004 Nov; 26(6):703-8. PubMed ID: 15600263
[TBL] [Abstract][Full Text] [Related]
33. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
34. Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
Ghandour H; Bagley PJ; Shemin D; Hsu N; Jacques PF; Dworkin L; Bostom AG; Selhub J
Kidney Int; 2002 Dec; 62(6):2246-9. PubMed ID: 12427152
[TBL] [Abstract][Full Text] [Related]
35. Therapy of hyperhomocysteinemia in end-stage renal disease patients.
Hagen W; Födinger M; Hörl WH; Sunder-Plass-Mann G
Minerva Urol Nefrol; 2001 Sep; 53(3):159-70. PubMed ID: 11723441
[TBL] [Abstract][Full Text] [Related]
36. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.
Lindner A; Bankson DD; Stehman-Breen C; Mahuren JD; Coburn SP
Am J Kidney Dis; 2002 Jan; 39(1):134-45. PubMed ID: 11774112
[TBL] [Abstract][Full Text] [Related]
37. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Elian KM; Hoffer LJ
Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of telomere length and LINE-1 methylation in peripheral blood cells: the role of B vitamins supplementation.
Pusceddu I; Herrmann M; Kirsch SH; Werner C; Hübner U; Bodis M; Laufs U; Wagenpfeil S; Geisel J; Herrmann W
Eur J Nutr; 2016 Aug; 55(5):1863-73. PubMed ID: 26293976
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
40. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
